Remynd

This early-stage trial tested the safety and tolerability of a new medicine called REM0045392, being developed for Alzheimer's disease. The study involved 19 healthy adults, including younger men and older men and women, who received either the drug or a placebo. The trial was te…

This study tested an experimental drug called REM0046127 in people with mild to moderate Alzheimer's disease. The goal was to see if it was safe and how it affected brain chemicals and brain wave activity. The trial was stopped early and included only 14 participants instead of t…